DENTSPLY SIRONA (NASDAQ:XRAY) Price Target Cut to $13.00 by Analysts at Barrington Research

DENTSPLY SIRONA (NASDAQ:XRAY) had its target price dropped by Barrington Research from $15.00 to $13.00 in a note issued to investors on Monday, Benzinga reports. The firm presently has an “outperform” rating on the medical instruments supplier’s stock. Barrington Research‘s price target suggests a potential upside of 37.86% from the stock’s previous close.

Other equities analysts have also issued research reports about the stock. Piper Sandler dropped their price objective on shares of DENTSPLY SIRONA from $14.00 to $12.00 and set a “neutral” rating on the stock in a report on Friday, October 9th. Weiss Ratings restated a “sell (e+)” rating on shares of DENTSPLY SIRONA in a research note on Monday, August 3rd. BMO Capital Markets decreased their target price on DENTSPLY SIRONA from $13.00 to $10.00 and set a “market perform” rating for the company in a research report on Thursday, September 17th. Leerink Partners decreased their target price on DENTSPLY SIRONA from $14.00 to $10.00 and set a “market perform” rating for the company in a research report on Wednesday, October 14th. Finally, Mizuho dropped their price target on DENTSPLY SIRONA from $14.00 to $12.00 and set a “neutral” rating on the stock in a research note on Thursday. Three research analysts have rated the stock with a Buy rating, eight have issued a Hold rating and three have assigned a Sell rating to the company. According to data from MarketBeat, the stock has a consensus rating of “Hold” and an average target price of $12.62.

DENTSPLY SIRONA Price Performance

DENTSPLY SIRONA stock opened at $9.43 on Monday. The company has a market capitalization of $1.88 billion, a PE ratio of -3.43, a PEG ratio of 1.20 and a beta of 0.87. DENTSPLY SIRONA has a 12-month low of $8.32 and a 12-month high of $14.76. The firm’s fifty day moving average is $9.87 and its 200 day moving average is $10.94. The company has a quick ratio of 1.07, a current ratio of 1.63 and a debt-to-equity ratio of 1.48.

DENTSPLY SIRONA (NASDAQ:XRAY) last posted its quarterly earnings results on Thursday, August 6th. The medical instruments supplier reported $0.52 EPS for the quarter, topping analysts’ consensus estimates of $0.35 by $0.17. The business had revenue of $898.00 million during the quarter, compared to analysts’ expectations of $889.93 million. DENTSPLY SIRONA had a negative net margin of 14.99% and a positive return on equity of 20.84%. The business’s quarterly revenue was down 4.1% on a year-over-year basis. During the same period last year, the company posted $0.52 earnings per share. DENTSPLY SIRONA has set its FY 2026 guidance at 1.400-1.500 EPS. As a group, sell-side analysts predict that DENTSPLY SIRONA will post 1.39 EPS for the current fiscal year.

Institutional Inflows and Outflows

Several hedge funds have recently modified their holdings of the stock. Nykredit A S purchased a new stake in DENTSPLY SIRONA in the 2nd quarter valued at $38,000. Allworth Financial LP bought a new position in DENTSPLY SIRONA during the 2nd quarter valued at $51,000. IFP Advisors Inc lifted its stake in DENTSPLY SIRONA by 244.4% during the 3rd quarter. IFP Advisors Inc now owns 5,566 shares of the medical instruments supplier’s stock valued at $49,000 after acquiring an additional 3,950 shares in the last quarter. Public Employees Retirement System of Ohio bought a new position in DENTSPLY SIRONA during the 2nd quarter valued at $69,000. Finally, Citizens Financial Group Inc. RI purchased a new position in DENTSPLY SIRONA during the 2nd quarter worth $118,000. Hedge funds and other institutional investors own 95.70% of the company’s stock.

DENTSPLY SIRONA Company Profile

DENTSPLY SIRONA is a global manufacturer of professional dental products and technologies. The company serves dentists, dental specialists, dental laboratories and other oral health professionals with solutions used in preventive, restorative, prosthetic, endodontic and implant dentistry.

Its portfolio includes dental equipment, imaging and treatment systems, CAD/CAM technology, consumable dental materials, orthodontic products, endodontic instruments and solutions, dental implants, prosthetic components and laboratory products.